Omega Therapeutics Inc
NASDAQ:OMGA
Omega Therapeutics Inc
NASDAQ:OMGA
Price:
2.31 USD
17.86%
Market Closed
Updated:
May 13, 2024
Balance Sheet
Balance Sheet Decomposition
Omega Therapeutics Inc
Omega Therapeutics Inc
| Current Assets | 89.9m |
| Cash & Short-Term Investments | 73.4m |
| Receivables | 7m |
| Other Current Assets | 9.5m |
| Non-Current Assets | 114.5m |
| PP&E | 114m |
| Other Non-Current Assets | 435k |
| Current Liabilities | 26.8m |
| Accounts Payable | 1.6m |
| Accrued Liabilities | 18.6m |
| Other Current Liabilities | 6.6m |
| Non-Current Liabilities | 119.5m |
| Long-Term Debt | 14.9m |
| Other Non-Current Liabilities | 104.7m |
Balance Sheet
Omega Therapeutics Inc
Omega Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
2
|
23
|
187
|
71
|
68
|
|
| Cash Equivalents |
2
|
23
|
187
|
71
|
68
|
|
| Short-Term Investments |
0
|
0
|
39
|
54
|
5
|
|
| Total Receivables |
0
|
0
|
1
|
2
|
7
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
6
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
|
| Other Current Assets |
0
|
1
|
3
|
11
|
9
|
|
| Total Current Assets |
3
|
24
|
229
|
138
|
90
|
|
| PP&E Net |
3
|
4
|
4
|
8
|
114
|
|
| PP&E Gross |
3
|
4
|
4
|
8
|
114
|
|
| Accumulated Depreciation |
1
|
3
|
4
|
5
|
6
|
|
| Other Long-Term Assets |
1
|
1
|
0
|
1
|
0
|
|
| Total Assets |
6
N/A
|
28
+361%
|
233
+730%
|
146
-37%
|
204
+40%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
2
|
3
|
2
|
|
| Accrued Liabilities |
1
|
3
|
9
|
15
|
19
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
3
|
0
|
3
|
4
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
3
|
|
| Total Current Liabilities |
2
|
8
|
12
|
22
|
27
|
|
| Long-Term Debt |
12
|
9
|
20
|
17
|
15
|
|
| Other Liabilities |
1
|
1
|
1
|
2
|
105
|
|
| Total Liabilities |
15
N/A
|
18
+14%
|
33
+87%
|
40
+22%
|
146
+266%
|
|
| Equity | ||||||
| Common Stock |
27
|
75
|
0
|
0
|
0
|
|
| Retained Earnings |
37
|
66
|
135
|
237
|
335
|
|
| Additional Paid In Capital |
1
|
2
|
335
|
344
|
393
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
9
N/A
|
11
N/A
|
201
+1 792%
|
106
-47%
|
58
-45%
|
|
| Total Liabilities & Equity |
6
N/A
|
28
+361%
|
233
+730%
|
146
-37%
|
204
+40%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
47
|
47
|
48
|
48
|
55
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
